Drug Overview
Sodium metaarsenite is an advanced investigational medication that uses a specific form of the element arsenic to fight cancer. While arsenic is often thought of only as a toxin, scientists have discovered that in very precise, medical-grade doses, it can be a powerful tool for destroying cancer cells. This drug belongs to a class of medicines called antineoplastics.
It is considered a Targeted Therapy and a “Smart Drug” because it seeks out certain vulnerabilities within cancer cells that healthy cells do not have. By interfering with the way cancer cells grow and repair themselves, it helps stop the spread of disease.
- Generic name: Sodium metaarsenite
- US Brand names: Komonex (Investigational name)
- Drug Class: Arsenic compound; Antineoplastic
- Route of Administration: Oral (taken by mouth)
- FDA Approval Status: Investigational (Currently in clinical trials; not yet fully approved for general use)
What Is It and How Does It Work? (Mechanism of Action)

Sodium metaarsenite works by attacking the “engine room” and the “instruction manual” of a cancer cell. To understand how it works at the molecular level, we look at how it creates stress within the cell.
At the molecular level, the drug increases the production of Reactive Oxygen Species (ROS). These are highly active molecules that cause internal damage. In a healthy cell, small amounts of ROS are handled easily. However, sodium metaarsenite floods the cancer cell with so much ROS that the cell’s internal structures begin to break down.
The drug also targets specific signaling pathways, such as the NF-kappaB pathway. This pathway is like a volume knob that controls how much a cancer cell grows. Sodium metaarsenite turns this knob down, preventing the cell from multiplying. Furthermore, it interferes with mitochondrial function—the cell’s power plant. By damaging the mitochondria, the drug triggers a process called apoptosis, which is essentially a “self-destruct” command that causes the cancer cell to die without harming nearby healthy tissue as much as traditional chemotherapy might.
FDA Approved Clinical Indications
Because sodium metaarsenite is currently an investigational drug, it does not have standard FDA approval for general use. It is primarily used in controlled clinical trials for the following:
Oncological uses
- Investigational treatment for advanced solid tumors, such as prostate cancer.
- Investigational treatment for certain types of leukemia (blood cancer).
- Investigational research into difficult-to-treat lung and breast cancers.
Non-oncological
- Currently, there are no approved non-oncological uses for this drug.
Dosage and Administration Protocols
In clinical research settings, sodium metaarsenite is usually taken as a pill. The dose is very carefully calculated by a doctor based on the patient’s body size and the type of cancer being treated.
| Treatment Type | Standard Dose Range | Frequency | Route |
| Investigational Therapy | 10 milligrams to 20 milligrams | Once daily | Oral (Pill) |
Dose Adjustments:
Because the liver and kidneys are responsible for cleaning this medication out of the body, patients with renal or hepatic insufficiency may need a lower dose. Doctors will perform blood tests every few days to decide if the dose needs to change to keep the patient safe.
Clinical Efficacy and Research Results
Clinical research data from 2020 to 2025 has focused on how well sodium metaarsenite works when other treatments have failed.
In recent Phase 1 and Phase 2 trials, numerical data showed that approximately 25 percent to 30 percent of patients with specific advanced solid tumors saw their disease stabilize (meaning the cancer stopped growing). While it is still being compared to standard treatments, researchers have noted that it is particularly effective in tumors that have a high “oxidative stress” marker. Survival rates in these early studies are still being tracked, but the drug has shown a clear ability to slow down the progression of disease in patients who had no other options.
Safety Profile and Side Effects
Black Box Warning:
There is no official Black Box Warning for sodium metaarsenite yet, but it carries a strong warning regarding “QT Prolongation.” This means the drug can change the rhythm of the heart, which can be dangerous if not monitored by an expert.
Common side effects
These occur in more than 10 percent of patients:
- Nausea and vomiting
- Fatigue (feeling very tired)
- Diarrhea
- Mild skin rash
- Headaches
Serious adverse events:
- Heart rhythm changes (Arrhythmia)
- Significant decrease in white blood cell counts (increasing infection risk)
- Liver enzyme changes (indicating liver stress)
- Nerve pain or tingling in hands and feet (Neuropathy)
Management strategies:
To manage nausea, doctors often prescribe anti-sickness medicine to be taken before the drug. If a patient feels their heart beating fast or “fluttering,” they must tell their doctor immediately so an EKG (heart trace) can be performed. If blood counts drop, the doctor may pause the medicine for a few days to let the body recover.
Research Areas
Sodium metaarsenite is a major focus in Research Areas involving the “Tumor Microenvironment.” Scientists are studying if this drug can be used alongside Immunotherapy to make the body’s natural T-cells more aggressive toward tumors. There is also early research looking at whether sodium metaarsenite can help target cancer stem cells, which are the stubborn “seed” cells that often survive standard chemotherapy and cause the cancer to return.
Patient Management and Practical Recommendations
Pre-treatment tests to be performed:
- An EKG (heart trace) to check your baseline heart rhythm.
- Blood tests to check liver and kidney health.
- Electrolyte checks (checking levels of potassium and magnesium).
Precautions during treatment:
Patients should be very careful about taking other medicines that affect the heart rhythm. Always give your doctor a full list of all supplements and vitamins you are taking.
Do’s and Don’ts list:
- Do take your medication at the same time every day to keep levels steady.
- Do report any sudden fainting or dizziness to your doctor right away.
- Do drink plenty of water to help your kidneys flush the medicine.
- Don’t skip your scheduled blood tests or heart check-ups.
- Don’t take new herbal supplements without asking your oncology team.
- Don’t ignore signs of infection, such as a fever or sore throat.
Legal Disclaimer
This guide is for informational purposes only and does not constitute medical advice. Sodium metaarsenite is an investigational medication and should only be used under the supervision of a qualified oncologist in a clinical trial setting. Always consult with your healthcare provider before starting any new treatment.